Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    30-January-2001      
Issue 30 Next Update - 14:00 UTC 08:00 EST    31-January-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article In Today's Vidyya
joint
The US FDA has approved an injectable medication for the treatment of osteoarthritis.


Proceed To Article FDA Approves New Treatment For Invasive Fungal Infection
The FDA has approved Cancidas (caspofungin acetate) Intravenous Infusion, a new anti-fungal medication for patients who are unresponsive to or cannot tolerate standard therapies for the invasive form of aspergillosis. Cancidas is the first approved drug in a new class of anti-fungal agents called echinocandins, which are believed to work by disrupting the creation of fungal cell walls. More...

Proceed To Article Drug Decreases Blood Vessel Stiffness In Older Primates
A novel drug that breaks down vascular collagen bonds in the body significantly decreased the stiffness of blood vessels in older non-human primates, according to a study conducted by National Institute on Aging (NIA) scientists and others. The finding suggests the medication could be a new treatment for high blood pressure, heart failure, and certain vascular complications of diabetes. More...

Proceed To Article NIH Course On Human Research Protections Goes Online
Vidyya keeps an eye on resources that will help our readers in their everyday lives. In that vein, we have discovered that the National Cancer Institute has developed a Web-based tool to help researchers, physicians, and nurses protect research participants. More...

Proceed To Article Study Underway To Test Anti-Inflammatory Medicines For Prevention Of Alzheimer's Disease
Alzheimer's disease affects up to 4 million Americans. If no cure is found, that number could double in 20 years as baby boomers age. On 30 January, the Alzheimer's Disease Anti-inflammatory Prevention Trial, or ADAPT, will begin to test whether anti-inflammatory pain relievers could prevent this degenerative brain disease. More...

Proceed To Article

New Osteoarthritis Drug Receives FDA Approval
Smith & Nephew Orthopaedics has received Food & Drug Administration approval for Supartz, a joint fluid therapy to treat osteoarthritis. In the United States, an estimated 20 million individuals suffer from osteoarthritis (OA) so the approval of another treatment will be welcome and successful. More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.